Santen Pharmaceutical Investor

Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.
Industry: Biotechnology, Health Care, Manufacturing, Science and Engineering
Headquarters: United States
Founded Date: 1890-01-01
Employees Number: 1001-5000
Funding Status: M&A
Number Of Exits: 3
Investors Number: 8
Total Funding: 59000000 EUR
Last Funding Date: 2009-09-26
Last Funding Type: Series D

Visit Website
info-USA@santen.com
https://twitter.com/santenusa
Register and Claim Ownership